United States · FDA National Drug Code directory
FLUTICASONE PROPIONATE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 58602-017_ef12e102-d407-457c-8f7b-ba7b91a6b733
- Product NDC
- 58602-017
- Form
- SPRAY, METERED
- Composition / generic term
- fluticasone propionate
- Labeler
- Aurohealth LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20240510
- Source listing expiry
- 20261231
Source-listed ingredients
- FLUTICASONE PROPIONATE — 50 ug/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (58602-017-42) / 60 SPRAY, METERED in 1 BOTTLE · 58602-017-42
- 1 BOTTLE in 1 CARTON (58602-017-43) / 120 SPRAY, METERED in 1 BOTTLE · 58602-017-43
- 1 BOTTLE in 1 CARTON (58602-017-45) / 72 SPRAY, METERED in 1 BOTTLE · 58602-017-45
- 2 BOTTLE in 1 CARTON (58602-017-46) / 72 SPRAY, METERED in 1 BOTTLE · 58602-017-46
- 3 BOTTLE in 1 CARTON (58602-017-47) / 72 SPRAY, METERED in 1 BOTTLE · 58602-017-47
- 1 BOTTLE in 1 CARTON (58602-017-48) / 144 SPRAY, METERED in 1 BOTTLE · 58602-017-48
- 2 BOTTLE in 1 CARTON (58602-017-49) / 144 SPRAY, METERED in 1 BOTTLE · 58602-017-49
- 3 BOTTLE in 1 CARTON (58602-017-50) / 144 SPRAY, METERED in 1 BOTTLE · 58602-017-50
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →